Mutations Position Table
PSEN1 G209 Mutations
| Mutation | Clinical Phenotype |
Pathogenicity | Neuropathology | Biological Effect | Genomic Position | Coding/Non-Coding | Genomic Region | Mutation Type Codon Change |
Research Models |
Primary Papers |
|---|---|---|---|---|---|---|---|---|---|---|
| G209A |
Alzheimer's Disease | AD : Pathogenic | Unknown; MRI showed global cortical atrophy and FDG-PET revealed widespread bilateral hypometabolism. | Unknown; predicted likely damaging in silico by PolyPhen2, SIFT, and Provean. | Coding | Exon 7 | Point, Missense GGA to GCA |
0 | An et al., 2016 | |
| G209E |
Alzheimer's Disease | AD : Pathogenic | Unknown, but MRI revealed global cerebral atrophy, particularly affecting the hippocampus. FDG-PET showed global hypometabolism, particularly affecting the temporal, parietal, and occipital lobes. | Unknown, but multiple in silico algorithms predicted a damaging effect. | rs63750053 |
Coding | Exon 7 | Point, Missense GGA to GAA |
0 | Rogaeva et al., 2001 |
| G209V |
Alzheimer's Disease | AD : Pathogenic | Neuropathology consistent with AD, includin cortical atrophy, extensive amyloid plaques and neurofibrillary tangles, and amyloid angiopathy. | Abrogated Aβ40 production and drastically reduced Aβ42 production in vitro. Also, caused incomplete endoproteolytic processing of PSEN1. | rs63750053 |
Coding | Exon 7 | Point, Missense GGA to GTA |
0 | Poorkaj et al., 1998 |
| G209R |
Alzheimer's Disease | AD : Pathogenic | Unknown; imaging showed mild brain atrophy in temporal lobes at early stages and diffuse brain atrophy mostly in frontotemporal lobes at advanced stages. Hypoperfusion in frontotemporal areas at early stages extending to parieto-occipital areas at advanced stages. CSF Aβ38, Aβ40, Aβ42, Aβ43 levels and Aβ43/Aβ42 were high vs other FAD carriers. | Abrogated Aβ40 production and drastically reduce Aβ42 production in vitro. | rs63749880 |
Coding | Exon 7 | Point, Missense GGA to AGA |
0 | Sugiyama et al., 1999 |
Disclaimer: Alzforum does not provide medical advice. The Content is for informational, educational, research and reference purposes only and is not intended to substitute for professional medical advice, diagnosis or treatment. Always seek advice from a qualified physician or health care professional about any medical concern, and do not disregard professional medical advice because of anything you may read on Alzforum.